1. Home
  2. KN vs VERA Comparison

KN vs VERA Comparison

Compare KN & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knowles Corporation

KN

Knowles Corporation

HOLD

Current Price

$23.13

Market Cap

1.8B

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$48.76

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KN
VERA
Founded
1946
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KN
VERA
Price
$23.13
$48.76
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$22.33
$76.60
AVG Volume (30 Days)
793.8K
1.3M
Earning Date
02-05-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.48
N/A
Revenue
$573,500,000.00
N/A
Revenue This Year
$9.26
N/A
Revenue Next Year
$5.87
N/A
P/E Ratio
$54.90
N/A
Revenue Growth
4.24
N/A
52 Week Low
$12.19
$18.53
52 Week High
$24.54
$56.05

Technical Indicators

Market Signals
Indicator
KN
VERA
Relative Strength Index (RSI) 56.48 56.84
Support Level $21.90 $47.28
Resistance Level $23.60 $50.79
Average True Range (ATR) 0.57 2.32
MACD 0.12 -1.14
Stochastic Oscillator 73.87 28.63

Price Performance

Historical Comparison
KN
VERA

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: